Nirav Patel

2.2K posts

Nirav Patel banner
Nirav Patel

Nirav Patel

@Patel_omics

Science & Technology Advisor @ 10X Genomics, views and opinion are my own. Passionate about Science, Technology, Business and Building Teams

Georgia, USA Katılım Şubat 2017
258 Takip Edilen365 Takipçiler
Nirav Patel retweetledi
10x Genomics
10x Genomics@10xGenomics·
The impossible is here: introducing Atera, uncompromised #spatialbiology that lets you analyze up to 800 1 cm2 whole transcriptome samples/year with #singlecell sensitivity. Register now for an in-depth look at our 4/21 webinar: bit.ly/4leeJ8X
10x Genomics tweet media
English
0
19
34
2.7K
Nirav Patel retweetledi
10x Genomics
10x Genomics@10xGenomics·
The stage is set and we’re finally raising the curtain in just a few hours! Watch for the full reveal at 7 PM PDT and make sure you register for our 4.21 webinar for a more in-depth look: bit.ly/4leeJ8X
10x Genomics tweet media
English
0
1
8
836
Nirav Patel retweetledi
10x Genomics
10x Genomics@10xGenomics·
The wait is almost over. Tomorrow, at 7 PM PDT, #10xGenomics invites you to witness the impossible. See what’s behind the curtain, then take a deeper dive in our 4.21 webinar. Register now: bit.ly/4leeJ8X
10x Genomics tweet media
English
0
2
5
706
Nirav Patel retweetledi
Caleb Lareau
Caleb Lareau@CalebLareau·
We’re very excited about combining rationally designed probes with short polymerase activity to read out native genotypes, and it’s really gratifying to see our colleagues anticipating the same: x.com/LGMartelotto/s… 14/n
Luciano Martelotto 🛠🧬💻🇦🇺@LGMartelotto

We GoT a Filling…uuuuhoooo 𝗧𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 𝗼𝗳 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻𝘀 𝘃𝗶𝗮 𝗥𝗡𝗔-𝘁𝗲𝗺𝗽𝗹𝗮𝘁𝗲𝗱 𝗴𝗮𝗽 𝗳𝗶𝗹𝗹𝗶𝗻𝗴 𝗼𝗳 𝗼𝗹𝗶𝗴𝗼𝗻𝘂𝗰𝗹𝗲𝗼𝘁𝗶𝗱𝗲𝘀 𝗳𝗼𝗿 𝘀𝗶𝗻𝗴𝗹𝗲-𝗰𝗲𝗹𝗹 𝗥𝗡𝗔-𝘀𝗲𝗾 Download here: biorxiv.org/content/10.648… 1/ 🧬 New preprint! We developed GoT-Multi-Gap — a method to detect expressed mutations in single cells without needing to know the variant sequence in advance. Built on RNA-templated gap filling. Thread 🧵👇 2/ The problem: detecting mutations in scRNA-seq is hard. Coverage is sparse, and capture methods lose sensitivity the farther a mutation sits from the transcript end. Ligation-based approaches (like our earlier GoT-Multi) require allele-specific probes — limiting scalability. 3/ Our solution: exploit the dual enzymatic activity of Bst FL polymerase. It reverse-transcribes across a gap between flanking probes on mRNA, then uses nick translation to activate the downstream probe for ligation. No allele-specific design needed. 4/ The trick: the downstream probe starts with a 5’-OH (ligation-incompetent). After Bst fills the gap and nicks the terminus, a 5’-phosphate is exposed → SplintR ligase seals the nick. The mutation sequence gets written into the product automatically. 5/ We validated the chemistry in situ with padlock probes + rolling circle amplification on 18S rRNA. Key insight: exonuclease-resistant backbone mods on the downstream probe fine-tune polymerase vs. nick-translation competition, boosting efficiency. 6/ We then built this into 10x Flex (GoT-Multi-Gap). Three cell lines (MCF-7, SK-BR-3, LnCAP), 61 SNVs targeted across a range of gap sizes. Critically — the gap-filling step didn’t perturb Flex performance. UMI counts, gene counts, correlations all preserved. 7/ Results: among targets with ≥10 genotyped cells, mutant calls showed 80-100% specificity to the expected cell line. The main driver of detection sensitivity? Target transcript abundance (Pearson R=0.37, P<0.01). 8/ What didn’t matter much: gap length (4-12 bp), mutation position within the gap, and probe GC content (within the 44-72% window). The assay captures variants across the full gap with comparable sensitivity. 9/ Bottom line: GoT-Multi-Gap enables simultaneous whole-transcriptome + multiplexed mutation profiling from the same single cell, without prior knowledge of variant identity. Scalable, compatible with existing workflows, and ready for complex mutational landscapes. 10/ Huge thanks to all authors and absolute special shout out to @MircaSaurty, @lee_hower and @Kellieiswise and the incredible team @WeillCornell and @scilifelab.

English
1
2
17
2.7K
Nirav Patel retweetledi
10x Genomics
10x Genomics@10xGenomics·
Science is filled with tales of researchers, asking the right questions with the right tools, doing the impossible. You have the question: you just need the tool. So how will you do the impossible? Join us at #AACR26 to find out > bit.ly/3PV1wGh
10x Genomics tweet media
English
0
2
7
513
Nirav Patel retweetledi
10x Genomics
10x Genomics@10xGenomics·
We’re proud to collaborate with @RocheDiaUSA in a shared commitment to supporting researchers with flexible, high-throughput, and trusted genomic data. This marks an important step forward in expanding sequencing options and scaling biological insights.
10x Genomics tweet media10x Genomics tweet media
English
0
1
6
702
Nirav Patel retweetledi
Shea Wihlborg
Shea Wihlborg@Shea_ARK·
Biology is becoming one of the largest data-generation engines on the planet – and AI is poised to help transform the scale and complexity of this data to reshape healthcare. The multiomics–AI flywheel is real and accelerating. I wrote a deeper look for @ARKInvest — the companies enabling and benefiting from it, key debates, and what comes next: @TwistBioscience — making it possible to write and engineer DNA at unprecedented scale and precision @TempusAI — 50%+ of US oncologists already connected, Tempus is building one of the deepest multimodal clinical-molecular data moats in healthcare @RecursionPharma — AI-native drug discovery and development platform hitting clinical proof points, including in a disease with zero approved therapies @CRISPRTx — scaling the first approved CRISPR therapy, now advancing gene editing from rare disease toward common diseases Read more here! 👇
ARK Invest@ARKInvest

The convergence of AI and biology is not a future possibility. It's underway. Which companies do we see building the future of healthcare? Read @Shea_ARK's The Multiomics–AI Flywheel: Why ARK Believes AI And Biology Are Converging To Reshape Healthcare arkinvestmentmanagement.substack.com/p/the-multiomi…

English
13
54
286
79.3K
Nirav Patel retweetledi
10x Genomics
10x Genomics@10xGenomics·
Single cell sequencing. #NGS-based spatial. High-plex in situ. These technologies were once impossible. Then they were improbable. Now they’re indispensable. So what will be next on that list? See what’s next: bit.ly/4qSSJl4
English
0
2
4
699
Nirav Patel retweetledi
10x Genomics
10x Genomics@10xGenomics·
We’re proud to partner with @bioptimus_ai and Broad Clinical Labs on STELA, a new global initiative to build the world’s largest clinically linked spatial biology atlas. Powered by Xenium, it will generate AI-ready datasets at unprecedented scale: bit.ly/4uYqbKj
10x Genomics tweet media
English
0
1
6
563
Nirav Patel retweetledi
10x Genomics
10x Genomics@10xGenomics·
Exciting news! Our Epi Multiome assay is getting the GEM-X performance upgrade with incredible benefits across the entire workflow, from more reliable sample prep to higher gene sensitivity and more. Pre-order today > bit.ly/47Nmflq
10x Genomics tweet media
English
0
1
3
666
Nirav Patel retweetledi
Vega Shah
Vega Shah@dr_alphalyrae·
Scalable probe-based single-cell transcriptional profiling for virtual cell perturbation mapping and synthetic biology phenotyping - from @arcinstitute
Vega Shah tweet media
English
2
4
64
4.9K
Nirav Patel retweetledi
Elliot Hershberg
Elliot Hershberg@ElliotHershberg·
More exceptional technology from the Arc Institute: "ProPer-seq faithfully reproduces gold-standard perturb-seq phenotypes while achieving 4-fold cost reduction and 50% increased gene detection per cell." Seems like a big improvement (in cost and resolution) for one of the most central methods in modern functional genomics. The required inputs to scale "virtual cell" models continue to plummet in cost...
Elliot Hershberg tweet media
English
6
26
168
29.2K
Nirav Patel retweetledi
Nirav Patel retweetledi
10x Genomics
10x Genomics@10xGenomics·
Yesterday we opened our European HQ at the @Leidenbsp! As remarked by @ministerVWS "Companies like 10x Genomics are in the vanguard of data-driven drug discovery. As a physician and as Minister of Health, Welfare and Sport, it seems to me that the future is already here."
10x Genomics tweet media10x Genomics tweet media10x Genomics tweet media10x Genomics tweet media
English
0
4
12
910
Nirav Patel retweetledi
10x Genomics
10x Genomics@10xGenomics·
In partnership with @CancerResearch, we’re combining our platforms with AI to build one of the world’s most comprehensive immuno-oncology datasets to drive the next generation of immunotherapies and vaccine discovery. More on our initiative with CRI: bit.ly/4qhIzLf
10x Genomics tweet media
English
0
4
7
952
Nirav Patel retweetledi
10x Genomics
10x Genomics@10xGenomics·
We are collaborating with @DanaFarber to analyze solid tumor samples using single-cell and spatial biology, with plans to establish a CLIA-certified lab to support a multi-year research effort toward future diagnostic workflows that support cancer care: bit.ly/3LJ59NP
10x Genomics tweet media
English
0
2
5
647